还没做过化疗，EGFR是野生型的病友一定要去做ALK的检测

jzjqian 发表于 2012-7-25 15:45

                               
登录/注册后可看大图

, [/ h( K- E# Y9 @3 G请教，像我这样的，手术22个月了，还能去原手术医院拿到病理作EGFR检查么？

可以，但要有针对性，

请问，肺鳞癌，只做过一次化疗，骨髓抑制严重，后吃特罗凯4个月基本无效，可以参加实验组吗？

不可以了,要没做过任何治疗的,包括化疗和靶向药

Concomitant EGFR mutation and EML4-ALK gene fusion in non-small cell lung cancer.  Print this page  

6 k! G2 P3 t9 I+ u8 Y8 q; T$ R% H
Sub-category:
# E, U( ]3 G, E0 ZMolecular Targets
$ T9 ?/ L: B& u
9 H$ N" j( k/ B3 c4 J/ x
Category:
Tumor Biology
/ V( _3 r! j0 w% q& t
% ~" X. s* t/ I5 Y. N1 k$ N
3 m+ l) _- C: [8 s( eMeeting:
# D' Q+ U& l1 m8 V' a9 C( E2011 ASCO Annual Meeting
: n" u7 Z+ ]5 R  F% P9 B/ }

1 T& b2 F% I0 c6 r( nSession Type and Session Title:
# T- d- k2 `; u$ k- f8 SPoster Discussion Session, Tumor Biology

# U6 x3 i# R1 ?% S+ V- o
2 J0 _) m. g: R  O* B5 TAbstract No:
10517
) Y) w- ?( |+ v

Citation:
* f, F5 T' h2 }& w1 ]) NJ Clin Oncol 29: 2011 (suppl; abstr 10517)


: Q2 {3 \% Y  l* xAuthor(s):
8 F( g# f9 b2 eJ. Yang, X. Zhang, J. Su, H. Chen, H. Tian, Y. Huang, C. Xu, Y. L. Wu; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China; Guangdong Lung Cancer Institute, Medical Research Center of Guangdong General Hospital, Guangzhou, China; Guangdong Lung Cancer Institute, Guangzhou, China; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China

& G: n/ J" k/ s6 o- r# B

Abstracts that were granted an exception in accordance with ASCO's Conflict of Interest Policy are designated with a caret symbol (^) here and in the printed Proceedings.

Abstract Disclosures

1 J9 i' k6 J# k) d/ z+ l! cAbstract:

/ v0 P  V6 |7 k! u0 u- M  j
: s, r& I' q2 x- h3 z% SBackground: The fusion of the anaplastic lymphoma kinase (ALK) with the echinoderm microtubule-associated protein-like 4 (EML4) and epidermal growth factor receptor (EGFR) mutations are considered mutually exclusive. Advanced non-small cell lung cancer (NSCLC) patients with EML4-ALK did not benefit from EGFR tyrosine kinase inhibitors (TKIs). Methods: Multiplex reverse transcriptase-polymerase chain reaction (RT-PCR) followed by sequencing was performed for EML4-ALK fusion status detection. EGFR and KRAS mutations were determined by direct DNA sequencing. Positive results of EML4-ALK fusion were also confirmed by RACE-coupled PCR sequencing. Results: From April 2010 to January 2011, 412 patients (398 with NSCLC; 14 with SCLC) were tested for mutation status of EGFR, KRAS and EML4-ALK respectively. Frequency of EML4-ALK fusion was 10.6% (42/398) in NSCLC patients. No patients with SCLC were found to have positive EML4-ALK fusion. Frequency of concomitant EGFR and EML4-ALK gene mutations was 1.0% (4/398) in NSCLC patients, and their variants of EML4-ALK gene mutations were Variant 1 (3 patients) and Variant 6 (1 patient); being never smokers, all of them were diagnosed with advanced (3 with stage †W and 1 with stage IIIB) adenocarcinoma harbouring wild type KRAS. Two female stage †W patients with double gene mutations (1 with L858R and Variant 1; 1 with exon19 deletion and Variant 6) received first-line gefitinib which is one kind of EGFR TKIs and achieved partial response. Conclusions: Though being rare events, NSCLC patients harbouring concomitant EGFR mutation and EML4-ALK gene fusion are sensitive to first-line EGFR TKIs. Whether they could also benefit from ALK inhibition after failure to EGFR TKIs warranted further investigation.

0 K5 `2 |" h& P. d  F) y
: q9 O) T# Y" \5 ~% t+ `

由吴一龙教授牵头的A80810029临床试验上周启动，初诊未治疗的晚期肺腺癌患者检测到ALK阳性，可参加一线crizotinib 对比力比泰+卡铂的临床研究，药物全部免费，即使分配到力比泰组，疾病进展之后可免费获得crizotinib.

没有手术，只化疗过，现吃靶向药，未突变，alk未测，有机会入组吗？

boeun 发表于 2012-11-18 16:37

" Q# ]' Y$ P, [% F5 h' E/ p                               
登录/注册后可看大图

& u) ~; x- }' U0 E- h/ F8 [没有手术，只化疗过，现吃靶向药，未突变，alk未测，有机会入组吗？

8 {% n6 e2 a% D4 ^) i% \化疗过的没机会了

平安！ 发表于 2012-7-20 11:20

+ m0 E; h) p4 x1 g                               
登录/注册后可看大图

, j" t  u% r' W6 O易瑞沙、特罗凯有效的病人基本上可以断定ALK（-）。极其罕见EGFR、ALK同时突变的。
ALK一个指标医院要900多 ...

平安，真的没有希望吗？我弟弟虽然特罗凯有效，但是ＥＧＦＲ是野生型，不是突变啊。有没有必要去检测ＡＬＫ呢？
! B8 E# c) a# V9 |- i0 x7 }* u
8 B  w% g$ e: I, u* e  ]- ?现在病情进展，快没招儿了。

好像想加入挺困难的

小地方没条件做啊